About Orion Oyj

Company Description

Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are oncology and pain.

Orion's customers are mainly healthcare service providers and professionals such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centres, clinics and laboratories. Consumers with pets are another important customer group.

Orion's main market is Finland, where it is the clear market leader. Orion’s products are marketed in over a hundred countries, and the Group's own human pharmaceuticals sales organisation covers almost all key European markets and a few Southeast Asian countries. In other markets Orion’s products are sold by several collaboration partners.

Served area

Worldwide

Headquarters

Orionintie 1A, 2200 Espoo – Finland

Shareholder information

Shares outstanding

141,134,278

IPO

July 3, 2006

Stock exchange(s)

Nasdaq Helsinki

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.